Skip to main content
Clinical Trials/NCT03370952
NCT03370952CompletedNot Applicable

Laparoscopy-assisted Ovarian Cystectomy: NEW APPROCH

Cairo University1 site in 1 country112 target enrollmentStarted: December 21, 2017Last updated:
Conditions
Interventions

Trial Snapshot

Phase
Not Applicable
Status
Completed
Enrollment
112
Locations
1
Primary Endpoint
recurrence of ovarian masses

Study Overview

Brief Summary

Under general anaesthesia, the patient is placed in the modified dorsal lithotomy position a 10-mm umbilical trocar is inserted. A panoramic view of the pelvis was obtained together with full assessment of the ovarian mass(es).

Aspiration of the cyst:

Veress needle is inserted in the midline 2 cm above the symphysis pubis to aspirate the cyst under laparoscopic guidance (to guide the entry of the needle into the cyst wall & to confirm complete aspiration).

Delivery of affected ovary outside the abdominal cavity:

Classic ovarian cystectomy will be done using microsurgical techniques in which the cyst wall will be dissected gently and carefully from the healthy ovarian tissue followed by perfect haemostasis and re-fashioning of the remaining ovarian tissue using Vicryl (3-0) sutures.

Re-introduction of the ovary to inside the abdominal cavity:

The stitched ovary is pushed gently inside the abdominal cavity and the mini-laparotomy is re-covered by the rubber shield (to allow re-inflation of the abdominal cavity). The ovary is reassessed under laparoscopic guidance to ensure perfect haemostasis and normal position of the ovary. Pelvic irrigation is done if needed.

Detailed Description

Patient positioning and port placement:

Under general anaesthesia, the patient is placed in themodified dorsal lithotomy position (to ensure lax anterior abdominal wall). The patient is thenprepped and draped in the usual fashion for an abdominaland vaginal procedure. In non- virgin patients, vaginal speculum is inserted into thevagina to expose the cervix, a uterine manipulator is inserted in the cervix followed by placement of a Foley's catheter in thebladder. As regards port placement, a 10-mm umbilical trocar is inserted. A panoramic view of the pelvis was obtained together with full assessment of the ovarian mass(es).

Aspiration of the cyst:

Veress needle is inserted in the midline 2 cm above the symphysis pubis to aspirate the cyst under laparoscopic guidance (to guide the entry of the needle into the cyst wall & to confirm complete aspiration).

Delivery of affected ovary outside the abdominal cavity:

Study Design

Study Type
Interventional
Allocation
Non Randomized
Intervention Model
Parallel
Primary Purpose
Treatment
Masking
None

Eligibility Criteria

Ages
20 Years to 35 Years (Adult)
Sex
Female
Accepts Healthy Volunteers
No

Inclusion Criteria

  • •unilateral or bilateral ovarian cysts (≥ 10 cm),
  • •recurrent ovarian cysts
  • •good ovarian reserve (antimullerian hormone {AMH} > 1 ng/ml & antral follicular count {AFC} > 4)

Exclusion Criteria

  • •solid ovarian masses
  • •patients who were unfit for surgery
  • •chronic diseases (e.g. cardiac disease or diabetes)
  • •any contraindication for laparoscopic surgery (excessive anterior abdominal wall scarring)

Arms & Interventions

new approach

Active Comparator

Under general anaesthesia, the patient is placed in the modified dorsal lithotomy position a 10-mm umbilical trocar is inserted. A panoramic view of the pelvis was obtained together with full assessment of the ovarian mass(es).

Aspiration of the cyst:

Delivery of affected ovary outside the abdominal cavity:

A transverse mini-laparotomy is done (2-3 cm) in the midline 2 cm above the symphysis pubis.

Ovarian cystectomy:

Re-introduction of the ovary to inside the abdominal cavity:

Intervention: combined laproscopic and minilaparotomy ovarian cystectomy (Procedure)

Laproscopic ovarian cystectomy

Active Comparator

classic laparoscopic ovarian cystectomy

Intervention: laproscopy (Procedure)

Outcomes

Primary Outcomes

recurrence of ovarian masses

Time Frame: 6 months after the operation

recurrence was defined as the presence of ovarian cysts ≥2 cm in the ipsilateral ovary

Secondary Outcomes

  • Serum antimullerian hormone(6 months after the operation)
  • serum follicle stimulating hormone(6 months after the operation)

Investigators

Sponsor Class
Other
Responsible Party
Principal Investigator
Principal Investigator

Ahmed M Maged, MD

professor

Cairo University

Study Sites (1)

Loading locations...

Similar Trials